Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients

Journal of Internal Medicine

Volumn 254, Issue 5, 2003, Pages 494-503

  Tenerz, A ^a,b   Nilsson, G ^a   Forberg, R ^b   Ohrvik J ^a   Malmberg, K ^c   Berne, C ^d   Leppert, J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Cortisol; Cox regression; Diabetes mellitus; Haemoglobin A1c; Non diabetic

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; GLUCOMETABOLIC STATUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART REINFARCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STRESS; SURVIVAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0242320403     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01221.x     Document Type: Article

References (30)

1. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-31.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-8.
3. Herlitz J, Bang A, Karlson BW. Mortality, place and mode of death and reinfarction during a period of 5 years after acute myocardial infarction in diabetic and non-diabetic patients. Cardiology 1996; 87: 423-8.
4. Melchior T, Kober L, Madsen CR, Seibaek M, Jensen GV, Hildebrandt P, Torp-Pedersen C. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Eur Heart J 1999; 20: 973-8.
5. Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care 1998; 21: 539-45.
6. Chowdhury TA, Lasker SS. Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998; 74: 480-1.
7. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.
8. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC - Norfolk). BMJ 2001; 322: 15-8.
9. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988; 9: 259-64.
10. Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001; 22: 1102-10.
11. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg. K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002: 359: 2140-4.
12. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986; 293: 917-22.
13. Donald RA, Crozier IG, Foy SG et al. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction. Clin Endocrinol (Oxf) 1994; 40: 499-504.
14. Bain RJ, Fox JP, Jagger J, Davies MK, Littler WA, Murray RG. Serum cortisol levels predict infarct size and patient mortality. Int J Cardiol 1992; 37: 145-50.
15. Stubbs PJ, Laycock J, Alaghband-Zadeh J, Carter G, Noble MI. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin Sci (Lond) 1999; 96: 589-95.
16. Prakash R, Parmley WW, Horvat M, Swan HJ, Serum cortisol, plasma free fatty acids, and urinary cathecholamines as indicators of complications in acute myocardial infarction. Circulation 1972; 45: 736-45.
17. Zouaghi H, Savu L, Guerot C, Gryman R, Coulon A, Nunez EA. Total and unbound cortisol-, progesterone-, oestrone-and transcortin-binding activities in sera from patients with myocardial infarction: evidence for differential responses of good and bad prognostic cases. Eur J Clin Invest 1985; 15: 365-70.
18. Jensen BA, Sanders S, Frolund B, Hjortrup A. Adrenocortical function in old age as reflected by plasma cortisol and ACTH test during the course of acute myocardial infarction. Arch Gerontol Geriatr 1988; 7: 289-96.
19. Adair R, Kasahara M. Serum cortisol response to acute myocardial infarction in the aged. J Am Geriatr Soc 1980; 28: 472-4.
20. Yudkin JS, Oswald GA. Hyperglycaemia, diabetes and myocardial infarction. Diabet Med 1987; 4: 13-8.
21. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 1996; 276: 1246-52.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
23. Hosmer DW, Lemeshow S. Applied Survival Analysis. Regression Modeling of Time t Event Data. New York: John Wiley & Sons. Inc., 229 pp.
24. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354: 617-21.
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
26. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ 1998; 317: 371-5.
27. Roberts R, Ambos HD, Sobel BE. Estimation of infarct size with MB rather than total CK. Int J Cardiol 1983; 2: 479-92.
28. Krieger DT, Allen W, Rizzo F, Krieger HP. Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 1971; 32: 266-84.
29. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000; 139: 272-81.
30. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Effect of diabetes mellitus on short-and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 1995; 130: 51-8.